CClinicalTrials.gg
RecruitingNCT06029062Updated Jun 3, 2026

tACS for Sensory Motor Recovery After Stroke

An interventional study of tACS Sham and tACS 10Hz in Motor Recovery, sponsored by The University of Texas Health Science Center, Houston. Recruiting at 1 site in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-06-03.

Sponsored by The University of Texas Health Science Center, Houston · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Sep 2025; still recruiting 1 year 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
14
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The overall goal is to investigate the effectiveness of a novel intervention - transcranial alternating current stimulation (tACS) for motor recovery in stroke survivors.

02

Conditions studied

  • Motor Recovery

Keywords

  • tACS
  • Motor recovery
03

In context

Lead sponsor

The University of Texas Health Science Center, Houston is the lead sponsor of 880 studies on the registry; 209 are open to participants now.

Of its 170 completed or terminated interventional studies of FDA-regulated products, 140 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion/exclusion criteria for stroke subjects

Inclusion criteria:

  1. Age between 18\~75 years old
  2. ≥ 6 months post stroke, medically stable;
  3. Unilateral, single stroke (no restriction on type (ischemic or hemorrhagic) or volume (large or small) of stroke);
  4. Visible finger flexor activation/movement
  5. The ability to give consent

Exclusion criteria:

  1. Patients with visual deficit/neglect; hearing or cognitive impairment;
  2. Patients that are currently adjusting tone alternating medications (e.g., baclofen), or
  3. Patients received botulinum toxin injection to the arm/fingers \<4 months, or phenol injections \<2 years;
  4. Patients with pacemaker, metal implants or supplemental oxygen;
  5. Patients who have musculoskeletal disorders, including pain in the affected side
  6. Women who are pregnant.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
14 participants (estimated)

Study arms

  • Experimental
    tACS Sham, tACS 10Hz, tACS 20Hz

    tACS Sham is a temporary non-invasive electrical stimulation that applies a weak oscillatory current to the brain through the scalp for up to 30 second, it is not designed to entrain neuronal activity into any external regulatory frequency patterns. tACS 10Hz is a 10Hz non-invasive electrical stimulation that applies a weak oscillatory current to the brain through the scalp or 20 or 40 minutes to entrain neuronal activity into 10Hz frequency patterns. tACS 20Hz is a 20Hz non-invasive electrical stimulation that applies a weak oscillatory current to the brain through the scalp for 20 or 40 minutes to entrain neuronal activity into 20Hz frequency patterns.

    Device: tACS Sham · Device: tACS 10Hz · Device: tACS 20Hz

  • Experimental
    HD-tACS 20Hz, HD-tACS 10Hz, HD-tACS Sham

    tACS Sham is a temporary non-invasive electrical stimulation that applies a weak oscillatory current to the brain through the scalp for up to 30 second, it is not designed to entrain neuronal activity into any external regulatory frequency patterns. tACS 10Hz is a 10Hz non-invasive electrical stimulation that applies a weak oscillatory current to the brain through the scalp or 20 or 40 minutes to entrain neuronal activity into 10Hz frequency patterns. tACS 20Hz is a 20Hz non-invasive electrical stimulation that applies a weak oscillatory current to the brain through the scalp for 20 or 40 minutes to entrain neuronal activity into 20Hz frequency patterns.

    Device: tACS Sham · Device: tACS 10Hz · Device: tACS 20Hz

  • Experimental
    HD-tACS 10Hz, HD-tACS 20Hz, HD-tACS Sham

    tACS Sham is a temporary non-invasive electrical stimulation that applies a weak oscillatory current to the brain through the scalp for up to 30 second, it is not designed to entrain neuronal activity into any external regulatory frequency patterns. tACS 10Hz is a 10Hz non-invasive electrical stimulation that applies a weak oscillatory current to the brain through the scalp or 20 or 40 minutes to entrain neuronal activity into 10Hz frequency patterns. tACS 20Hz is a 20Hz non-invasive electrical stimulation that applies a weak oscillatory current to the brain through the scalp for 20 or 40 minutes to entrain neuronal activity into 20Hz frequency patterns.

    Device: tACS Sham · Device: tACS 10Hz · Device: tACS 20Hz

Interventions

  • DevicetACS Sham

    Sham tACS will applied to the brain through the scalp for 20 minutes.

  • DevicetACS 10Hz

    10Hz tACS will applied to the brain through the scalp for 20 minutes.

  • DevicetACS 20Hz

    20Hz tACS will applied to the brain through the scalp for 20 minutes.

06

What researchers measure

Primary outcomes

  1. Block and Box Test (BBT) of Motor functional test

    The Box and Block Test (BBT) measures unilateral gross manual dexterity. It is a quick and simple test used with a wide range of populations, including clients with stroke.

    Time frame: Change of BBT performance 5 minutes before and 5 minutes after the tACS intervention will be measured.

  2. EEG alpha band and Beta band

    Electroencephalography (EEG) is valuable to infer and evaluate the neural interaction. Components of the alpha and beta frequency bands like the sensorimotor rhythm originated from the primary motor cortex and related brain areas reflect human movement. The power of 8-13 Hz alpha and 14-30 Hz beta frequency bands will be used for the classification.

    Time frame: Change of EEG alpha band and Beta band 5 minutes before and 5 minutes after the tACS intervention will be measured.

07

Study locations

1 of 1 sites recruiting
  • The University of Texas Health Science Center
    Houston, Texas 77030, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06029062
Lead sponsor
The University of Texas Health Science Center, Houston
Responsible party
Sheng Li (Professor, The University of Texas Health Science Center, Houston) — Principal investigator
First posted
Sep 8, 2023
Start date
Sep 1, 2025
Primary completion
Sep 30, 2027 (estimated)
Completion
Mar 31, 2028 (estimated)
Last update
Jun 3, 2026

Study contacts

Sheng Li, MD, Ph.D
Contact
sheng.li@uth.tmc.edu
(713) 797-7125
Shengai Li, MS
Contact
shengai.li@uth.tmc.edu
713-797-7561
Sheng Li, MD, Ph.D
principal investigator · The University of Texas Health Science Center, Houston

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion